logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Ventirx Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 80.0



Forward Citations = 33

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Robert Hershberg (9 out of 17 patents)

silverMedal Gregory Dietsch (7 out of 13 patents)

bronzeMedal James Jeffry Howbert (6 out of 6 patents)

4.  Laurence Edward Burgess (6 out of 45 patents)

5.  Brad Newhouse (3 out of 20 patents)

6.  Joseph P Lyssikatos (3 out of 141 patents)

7.  J Jeffry Howbert (3 out of 41 patents)

8.  Hong Woon Yang (3 out of 17 patents)

9.  Muralikrishna Duvvuri (2 out of 5 patents)

10.  George A Doherty (2 out of 53 patents)

11.  Hong-Woon Yang (2 out of 12 patents)

12.  C Todd Eary (2 out of 6 patents)

13.  Robert D Groneberg (2 out of 20 patents)

14.  Zachary Jones (2 out of 6 patents)

15.  Venkat Kusukuntla (1 out of 6 patents)


10 patents:

1. 10016440 - Methods of enhancing antibody-dependent cellular cytotoxicity (2018-07-10),
2. 9718796 - Substituted benzoazepines as toll-like receptor modulators (2017-08-01),
3. 9655904 - Substituted benzoazepines as toll-like receptor modulators (2017-05-23),
4. 9242964 - Substituted benzoazepines as toll-like receptor modulators (2016-01-26),
5. 9216192 - Toll-like receptor agonist formulations and their use (2015-12-22),
6. 9126940 - Substituted benzoazepines as toll-like receptor modulators (2015-09-08),
7. 8691809 - Substituted benzoazepines as toll-like receptor modulators (2014-04-08),
8. 8524702 - Substituted benzoazepines as toll-like receptor modulators (2013-09-03),
9. 8314090 - Methods of synthesis of benzazepine derivatives (2012-11-20),
10. 8242106 - Toll-like receptor agonist formulations and their use (2012-08-14),
Company Overview
Ventirx Pharmaceuticals, Inc. is a biotechnology company based in Seattle, WA, focused on developing innovative therapies for cancer treatment. The company specializes in harnessing the power of its proprietary drug delivery systems and immune-oncology approaches to create targeted therapies that aim to improve patient outcomes. Ventirx is dedicated to advancing its research in the field of immunotherapy, leveraging cutting-edge technology to address unmet medical needs in oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#202 in Seattle, WA

#687 in Washington

#29,892 in US

#56,119 in the World

Seattle, WA (US)
Seattle, WA, United States of America

Ventirx Pharmaceuticals, Inc.

Forward Citations = 33

19 inventors:

goldMedal Robert Hershberg (9 out of 17 patents)

silverMedal Gregory Dietsch (7 out of 13 patents)

bronzeMedal James Jeffry Howbert (6 out of 6 patents)

4.  Laurence Edward Burgess (6 out of 45 patents)

5.  Brad Newhouse (3 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ventirx Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/ventirx-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…